| 000 | 01882 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250513205558.0 | ||
| 264 | 0 | _c20000616 | |
| 008 | 200006s 0 0 eng d | ||
| 022 | _a0006-2960 | ||
| 024 | 7 |
_a10.1021/bi992372u _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFowler, S M | |
| 245 | 0 | 0 |
_aAmino acid 305 determines catalytic center accessibility in CYP3A4. _h[electronic resource] |
| 260 |
_bBiochemistry _cApr 2000 |
||
| 300 |
_a4406-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAlanine _xgenetics |
| 650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
| 650 | 0 | 4 | _aAryl Hydrocarbon Hydroxylases |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 |
_aCatalysis _xdrug effects |
| 650 | 0 | 4 |
_aClotrimazole _xpharmacology |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 | _aCytochrome P-450 Enzyme Inhibitors |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xchemistry |
| 650 | 0 | 4 |
_aDiazepam _xmetabolism |
| 650 | 0 | 4 |
_aEconazole _xpharmacology |
| 650 | 0 | 4 |
_aErythromycin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xchemistry |
| 650 | 0 | 4 |
_aKetoconazole _xmetabolism |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMiconazole _xpharmacology |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMultienzyme Complexes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 |
_aNifedipine _xmetabolism |
| 650 | 0 | 4 |
_aOxidoreductases, N-Demethylating _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTestosterone _xmetabolism |
| 700 | 1 | _aRiley, R J | |
| 700 | 1 | _aPritchard, M P | |
| 700 | 1 | _aSutcliffe, M J | |
| 700 | 1 | _aFriedberg, T | |
| 700 | 1 | _aWolf, C R | |
| 773 | 0 |
_tBiochemistry _gvol. 39 _gno. 15 _gp. 4406-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/bi992372u _zAvailable from publisher's website |
| 999 |
_c10711318 _d10711318 |
||